| A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (NCT03497767) | Trans Tasman Radiation Oncology Group | 2019-08-15 |
| A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (NCT03997539) | Sun Yat-sen University | 2019-08-15 |
| Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NCT04043195) | Hatim Husain | 2019-08-14 |
| The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) (NCT04073498) | ApcinteX Ltd | 2019-08-14 |
| Pharmacokinetics-pharmacodynamics and Safety of Dexmedetomidine in Children (NCT04027829) | Seoul National University Hospital | 2019-08-14 |
| Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis (NCT04048876) | Celgene | 2019-08-14 |
| Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA) (NCT04280536) | National University Hospital, Singapore | 2019-08-14 |
| Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (NCT03340129) | Melanoma Institute Australia | 2019-08-14 |
| Efficacy and Safety of Oral BT-11 in Ulcerative Colitis (NCT03861143) | NImmune Biopharma | 2019-08-14 |
| Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery (NCT03841058) | Hospital for Special Surgery, New York | 2019-08-14 |
| Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma (NCT03994913) | CARsgen Therapeutics Co., Ltd. | 2019-08-14 |
| A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT04077723) | Hoffmann-La Roche | 2019-08-13 |
| Optimizing Anesthesia for Post Partum Tubal Ligations (NCT03993314) | University of Alabama at Birmingham | 2019-08-13 |
| Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT04044768) | USWM CT, LLC | 2019-08-13 |
| Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis (NCT04024891) | Ocuphire Pharma, Inc. | 2019-08-13 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery (NCT04089735) | Formosa Pharmaceuticals, Inc. | 2019-08-13 |
| Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis (NCT03760003) | Abivax S.A. | 2019-08-13 |
| Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT03946878) | M.D. Anderson Cancer Center | 2019-08-13 |
| Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART (NCT03787095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-13 |
| Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma (NCT03531645) | M.D. Anderson Cancer Center | 2019-08-13 |
| Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis (NCT03977480) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-08-13 |
| Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates (NCT03519061) | Kaiser Permanente | 2019-08-13 |
| Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib (NCT04056572) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-08-13 |
| Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children (NCT03943888) | Seoul National University Hospital | 2019-08-12 |
| Boost Brittle Bones Before Birth (NCT03706482) | Karolinska Institutet | 2019-08-12 |
| Gene Therapy for Achromatopsia (CNGA3) (NCT03758404) | MeiraGTx UK II Ltd | 2019-08-12 |
| Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis (NCT04189419) | SCM Lifescience Co., LTD. | 2019-08-12 |
| Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome (NCT03951077) | AbbVie | 2019-08-12 |
| The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects (NCT05287425) | Medical University of Vienna | 2019-08-12 |
| A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors (NCT03972657) | Regeneron Pharmaceuticals | 2019-08-12 |
| Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study (NCT04067011) | Emergent BioSolutions | 2019-08-12 |
| Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (NCT04031508) | Coordinación de Investigación en Salud, Mexico | 2019-08-12 |
| Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients (NCT04083157) | The University of Hong Kong | 2019-08-12 |
| A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma (NCT04061772) | Zhejiang Cancer Hospital | 2019-08-12 |
| Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy (NCT03742193) | Ruijin Hospital | 2019-08-11 |
| Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia (NCT04522869) | Vinmec Research Institute of Stem Cell and Gene Technology | 2019-08-10 |
| Efficacy of Extract of Trigonella Foenum-graceum as Topical Phytoestrogen in Skin Aging Treatment of Post Menopausal Women (NCT04123743) | Indonesia University | 2019-08-10 |
| A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia (NCT04440059) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-08-10 |
| Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke (NCT04256473) | Erasmus Medical Center | 2019-08-10 |
| Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility. (NCT04099381) | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 2019-08-10 |
| Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome (NCT04308811) | Ain Shams University | 2019-08-10 |
| RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (NCT04037358) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-09 |
| Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military (NCT04058132) | Uniformed Services University of the Health Sciences | 2019-08-09 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients (NCT04368507) | CellabMED | 2019-08-09 |
| CXA-10 Study in Subjects With Pulmonary Arterial Hypertension (NCT04053543) | Complexa, Inc. | 2019-08-09 |
| Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies (NCT04068597) | CellCentric Ltd. | 2019-08-09 |
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer (NCT04001829) | ECOG-ACRIN Cancer Research Group | 2019-08-09 |
| Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer (NCT04083963) | University of Illinois at Chicago | 2019-08-09 |
| A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer (NCT03735680) | OncoNano Medicine, Inc. | 2019-08-09 |
| Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma (NCT03712904) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2019-08-09 |
| Pan Tumor Rollover Study (NCT03899155) | Bristol-Myers Squibb | 2019-08-09 |
| Postoperative Pain Management in Rhinoplasty (NCT03584152) | Stanford University | 2019-08-09 |
| Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT04003974) | Fulcrum Therapeutics | 2019-08-09 |
| Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation (NCT03513471) | University of North Carolina, Chapel Hill | 2019-08-09 |
| Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant (NCT03622788) | M.D. Anderson Cancer Center | 2019-08-08 |
| Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects (NCT04173962) | Icahn School of Medicine at Mount Sinai | 2019-08-08 |
| Aquamin® as an Adjuvant Intervention for Ulcerative Colitis (NCT03869905) | Muhammad N Aslam, MD | 2019-08-08 |
| Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis (NCT03903913) | SolAeroMed Inc. | 2019-08-08 |
| Camrelizumab Combined With Apatinib for Recurrent Resistant GTN (NCT04047017) | Peking Union Medical College Hospital | 2019-08-08 |
| A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China (NCT04015778) | Guangdong Association of Clinical Trials | 2019-08-08 |
| Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K) (NCT06400251) | National Cancer Institute (NCI) | 2019-08-08 |
| Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial (NCT03991013) | University of Cape Town | 2019-08-08 |
| Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases (NCT02859415) | National Cancer Institute (NCI) | 2019-08-08 |
| Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030) (NCT03940586) | Merck Sharp & Dohme LLC | 2019-08-08 |
| Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders (NCT03946111) | Yale University | 2019-08-07 |
| A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy (NCT03779334) | Hoffmann-La Roche | 2019-08-07 |
| Phase II Study With Cabozantinib in Patients With RET Positive NSCLC (NCT04131543) | University of Bologna | 2019-08-07 |
| Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer (NCT04030455) | M.D. Anderson Cancer Center | 2019-08-07 |
| Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) (NCT03983018) | Region Örebro County | 2019-08-07 |
| T-regulatory Cells in ALS (NCT04055623) | The Methodist Hospital Research Institute | 2019-08-07 |
| A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN (NCT04032093) | Pfizer | 2019-08-07 |
| Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) (NCT03945292) | Arrowhead Pharmaceuticals | 2019-08-07 |
| Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma (NCT04180995) | Peking University Cancer Hospital & Institute | 2019-08-06 |
| PRACTECAL-PKPD Sub Study (NCT04081077) | Medecins Sans Frontieres, Netherlands | 2019-08-06 |
| Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (NCT04002622) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-08-06 |
| Lidocaine Before Esophageal Manometry and Ambulatory pH Monitoring (NCT03967197) | Centre hospitalier de l'Université de Montréal (CHUM) | 2019-08-06 |
| Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer (NCT04022343) | Emory University | 2019-08-06 |
| An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis (NCT03896295) | Momenta Pharmaceuticals, Inc. | 2019-08-06 |
| Understanding Cognition, Oxytocin & Pain in Elders (NCT03878589) | University of Florida | 2019-08-06 |
| Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (NCT03860844) | Sanofi | 2019-08-06 |
| Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness (NCT03824834) | Dennis Jensen, Ph.D. | 2019-08-06 |
| The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. (NCT04065282) | First Affiliated Hospital of Zhejiang University | 2019-08-06 |
| Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma (NCT04002947) | National Cancer Institute (NCI) | 2019-08-05 |
| Saline Injections vs Education and Exercise in Knee Osteoarthritis (NCT03843931) | Marius Henriksen | 2019-08-05 |
| Rhopressa for Corneal Edema Associated With Fuchs Dystrophy (NCT04051463) | Price Vision Group | 2019-08-05 |
| A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (NCT04072952) | Arvinas Estrogen Receptor, Inc. | 2019-08-05 |
| Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy (NCT04056949) | Junling Li | 2019-08-05 |
| Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy (NCT03907397) | Scott Sicherer | 2019-08-05 |
| A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma (NCT03999684) | Dana-Farber Cancer Institute | 2019-08-05 |
| A Trial of Vitamin B12 in Septic Shock (NCT03783091) | Medical College of Wisconsin | 2019-08-05 |
| Gamma Induction for Alzheimer's Disease (NCT03880240) | Massachusetts General Hospital | 2019-08-05 |
| Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation (NCT04010994) | University of Magdeburg | 2019-08-05 |
| Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax (NCT04016805) | TG Therapeutics, Inc. | 2019-08-05 |
| Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder (NCT06680505) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2019-08-04 |
| A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease (NCT04084483) | Kowa Research Institute, Inc. | 2019-08-04 |
| Derazantinib and Atezolizumab in Patients With Urothelial Cancer (NCT04045613) | Basilea Pharmaceutica | 2019-08-02 |
| An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection (NCT03988855) | Deinove | 2019-08-02 |
| Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users (NCT03962283) | Chinese University of Hong Kong | 2019-08-02 |
| Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer (NCT03871153) | Greg Durm, MD | 2019-08-02 |
| Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal (NCT04070157) | USWM, LLC (dba US WorldMeds) | 2019-08-02 |